TELA Bio (TELA) Net Equity Issued and Repurchased (2020 - 2023)

TELA Bio's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at -$13000.0 for Q3 2023.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$13000.0 in Q3 2023; TTM through Dec 2023 was $46.0 million, a 49.28% decrease from a year earlier, with the FY2023 full-year figure at $46.3 million, up 34.71% from the prior year.
• Net Equity Issued and Repurchased declined to -$13000.0 in Q3 2023 per TELA's latest filing, from $46.3 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $46.3 million in Q2 2022 and bottomed at -$275000.0 in Q4 2022.
• The 3-year median for Net Equity Issued and Repurchased is $44.7 million (2020), against an average of $27.4 million.
• Biggest YoY gain for Net Equity Issued and Repurchased was 0.0% in 2023; the steepest drop was 0.0% in 2023.
• Year by year, Net Equity Issued and Repurchased stood at $44.7 million in 2020, then sank by 100.62% to -$275000.0 in 2022, then surged by 95.27% to -$13000.0 in 2023.
• Per Business Quant, the three latest TELA Net Equity Issued and Repurchased figures stand at -$13000.0 (Q3 2023), $46.3 million (Q2 2023), and -$275000.0 (Q4 2022).